VWA
BLFS icon

VSM Wealth Advisory’s BioLife Solutions BLFS Stock Holding History

VSM Wealth Advisory’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+5,000
New +$117K ﹤0.01% 505

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VSM Wealth Advisory's BLFS Position: Q2 2026 in Review

VSM Wealth Advisory opened a new position in BioLife Solutions (BLFS) in Q2 2026: 5,000 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #505 among its holdings.

216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • VSM Wealth Advisory held 5,000 shares of BioLife Solutions worth $0 as of Q2 2026.
  • BioLife Solutions was a new VSM Wealth Advisory position in Q2 2026.
  • BioLife Solutions made up ﹤0.01% of VSM Wealth Advisory's portfolio in Q2 2026, its #505 holding.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.